(1)
Omar, R. M. K.; Najar, A. M.; Bobtaina, E.; Elsheikh, A. F. Pryazolylpyridine and Triazolylpyridine Derivative of Hydroxychloroquine As Potential Therapeutic Against COVID-19: Theoretical Evaluation. J. Drug Delivery Ther. 2020, 10 (4-s), 181-186. https://doi.org/10.22270/jddt.v10i4-s.4298.